Clinical Analysis of Severe Pulmonary Fungal Infection in Intensive Care Unit
Abstract
Objective: To analyze the characteristics of ICU patients with severe pulmonary fungal infection and the effect of preventive medicine. Method: The study group of 68 cases in the discovery of fungal infection associated with adverse symptoms before clinical implementation of preventive antibiotics, the control group of 52 cases in the discovery of symptoms and the diagnosis of fungal infection after symptomatic application of antibiotics. The efficacy of the two groups was compared and the characteristics of fungal infection were analyzed. Results: The effective rate of the study group was significantly higher than control group (p < 0.05). The proportion of Candida albicans was the highest, and was significantly higher than that of smooth Candida glabrata and Candida parapsilosis, (p < 0.01). Conclusion: For the treatment of ICU severe pulmonary fungal infection in patients with the use of prophylactic antibiotics can improve the treatment effect of fungal infection, clinical medication should pay attention to avoid abuse and analysis of the characteristics of drug use.
References
2. Liu JL, Lv XD, Zhang YQ. 70 years of age or older patients with chronic obstructive pulmonary disease with pulmonary fungal infection, diagnosis and analysis. International Respiratory Journal. 2012;32(21):1616‒1618.
3. Han PW, Zhang H, et al. 2011 American Thoracic Society in adult pulmonary and critical care patients with fungal infection treatment guidelines profile. International Journal of Respiration. 2011;31(8):561‒562.
4. Wang GH. Clinical analysis of 72 cases of pulmonary fungal infection. Chinese Modern Pharmaceutical Applications. 2013;7(2):18‒20.
5. Jiang N, Huang J. Clinical analysis of nosocomial pulmonary fungal infection in patients in Department of respiration. Chinese Medicine Guide. 2013;11(1):211‒212.
6. Liu ZY. The clinical characteristics of pulmonary fungal infection in elderly patients. Chinese Medicine Guide. 2012;20(10):63‒65.
Copyright (c) 2013 Qing Ye

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors submitting to USP journals agree to publish their manuscript under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0) where authors agree to allow third parties to share their work (copy, distribute, transmit) and to adapt it, under the condition that the authors are given credit, and that in the event of reuse or distribution, the terms of this license are made clear
Authors retain copyright of their work, with first publication rights (online and print) granted to Universe Scientific Publishing or the owner of the journal in question.